Vanguard Group’s Verrica Pharmaceuticals VRCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
2,168,310
-193,011
| -8% | -$102K | ﹤0.01% | 3705 |
|
|
2025
Q1 | $1.04M | Buy |
2,361,321
+481,407
| +26% | +$213K | ﹤0.01% | 3697 |
|
|
2024
Q4 | $1.32M | Buy |
1,879,914
+593,314
| +46% | +$415K | ﹤0.01% | 3677 |
|
|
2024
Q3 | $1.87M | Buy |
1,286,600
+17,134
| +1% | +$24.8K | ﹤0.01% | 3577 |
|
|
2024
Q2 | $9.25M | Buy |
1,269,466
+756
| +0.1% | +$5.51K | ﹤0.01% | 2978 |
|
|
2024
Q1 | $7.51M | Buy |
1,268,710
+7,609
| +0.6% | +$45K | ﹤0.01% | 3119 |
|
|
2023
Q4 | $9.23M | Buy |
1,261,101
+34,243
| +3% | +$251K | ﹤0.01% | 2987 |
|
|
2023
Q3 | $4.77M | Buy |
1,226,858
+2,417
| +0.2% | +$9.39K | ﹤0.01% | 3271 |
|
|
2023
Q2 | $7.07M | Buy |
1,224,441
+106,664
| +10% | +$615K | ﹤0.01% | 3138 |
|
|
2023
Q1 | $7.27M | Buy |
1,117,777
+94,989
| +9% | +$617K | ﹤0.01% | 3125 |
|
|
2022
Q4 | $2.81M | Buy |
1,022,788
+10,192
| +1% | +$28K | ﹤0.01% | 3539 |
|
|
2022
Q3 | $2.96M | Hold |
1,012,596
| – | – | ﹤0.01% | 3593 |
|
|
2022
Q2 | $1.95M | Buy |
1,012,596
+320,437
| +46% | +$615K | ﹤0.01% | 3819 |
|
|
2022
Q1 | $5.61M | Sell |
692,159
-36
| -0% | -$292 | ﹤0.01% | 3472 |
|
|
2021
Q4 | $6.34M | Buy |
692,195
+19
| +0% | +$174 | ﹤0.01% | 3482 |
|
|
2021
Q3 | $8.65M | Buy |
692,176
+4,365
| +0.6% | +$54.6K | ﹤0.01% | 3334 |
|
|
2021
Q2 | $7.77M | Sell |
687,811
-22,872
| -3% | -$258K | ﹤0.01% | 3342 |
|
|
2021
Q1 | $10.8M | Buy |
710,683
+115,031
| +19% | +$1.74M | ﹤0.01% | 3103 |
|
|
2020
Q4 | $6.86M | Buy |
595,652
+9,313
| +2% | +$107K | ﹤0.01% | 3189 |
|
|
2020
Q3 | $4.54M | Sell |
586,339
-9,159
| -2% | -$70.9K | ﹤0.01% | 3198 |
|
|
2020
Q2 | $6.56M | Buy |
595,498
+16,013
| +3% | +$176K | ﹤0.01% | 2973 |
|
|
2020
Q1 | $6.34M | Buy |
579,485
+7,047
| +1% | +$77K | ﹤0.01% | 2848 |
|
|
2019
Q4 | $9.1M | Buy |
572,438
+28,799
| +5% | +$458K | ﹤0.01% | 2903 |
|
|
2019
Q3 | $8.02M | Buy |
543,639
+86,536
| +19% | +$1.28M | ﹤0.01% | 2928 |
|
|
2019
Q2 | $5.31M | Buy |
457,103
+25,858
| +6% | +$300K | ﹤0.01% | 3147 |
|
|
2019
Q1 | $4.66M | Buy |
431,245
+26,003
| +6% | +$281K | ﹤0.01% | 3165 |
|
|
2018
Q4 | $3.3M | Buy |
405,242
+112,753
| +39% | +$919K | ﹤0.01% | 3222 |
|
|
2018
Q3 | $4.75M | Buy |
292,489
+264,651
| +951% | +$4.3M | ﹤0.01% | 3257 |
|
|
2018
Q2 | $549K | Buy |
+27,838
| New | +$549K | ﹤0.01% | 3807 |
|